Kenji Imamachi

4PUBLICATIONS
10CO-AUTHORS
ChemotherapyPredictive and prognostic markersFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 14, 2026
Efficacy and risks of drug holiday in the management of medication-related osteonecrosis of the jaw in cancer patients: a single-center retrospective study.

Hironobu Hata, Kenji Imamachi, Kazuhito Yoshikawa

|Nov 01, 2022
Response to: Prognosis of metastatic bone cancer and myeloma patients and long‑term risk of medication‑related osteonecrosis of the jaw (MRONJ): some critical points.

Hironobu Hata, Kenji Imamachi, Michihiro Ueda

|Feb 03, 2022
Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study.

Hironobu Hata, Kenji Imamachi, Michihiro Ueda

Pageof 1